View in EDS HTML Full Text PDF Full Text

Low‐dose hydrocortisone in patients with COVID‐19 and severe hypoxia: The COVID STEROID randomised, placebo‐controlled trial.

Saved in:
Bibliographic Details
Title: Low‐dose hydrocortisone in patients with COVID‐19 and severe hypoxia: The COVID STEROID randomised, placebo‐controlled trial.
Authors: Munch, Marie Warrer1,2 (AUTHOR) marie.warrer.munch@regionh.dk, Meyhoff, Tine Sylvest1,2 (AUTHOR), Helleberg, Marie3 (AUTHOR), Kjær, Maj‐Brit Nørregaard1,2 (AUTHOR), Granholm, Anders1,2 (AUTHOR), Hjortsø, Carl Johan Steensen1,2 (AUTHOR), Jensen, Thomas Steen1,2 (AUTHOR), Møller, Morten Hylander1,2 (AUTHOR), Hjortrup, Peter Buhl1,2 (AUTHOR), Wetterslev, Mik1,2 (AUTHOR), Vesterlund, Gitte Kingo1,2 (AUTHOR), Russell, Lene1,2 (AUTHOR), Jørgensen, Vibeke Lind4 (AUTHOR), Kristiansen, Klaus Tjelle5 (AUTHOR), Benfield, Thomas6 (AUTHOR), Ulrik, Charlotte Suppli7 (AUTHOR), Andreasen, Anne Sofie8 (AUTHOR), Bestle, Morten Heiberg2,9,10 (AUTHOR), Poulsen, Lone Musaeus11 (AUTHOR), Hildebrandt, Thomas12 (AUTHOR)
Source: Acta Anaesthesiologica Scandinavica. Nov2021, Vol. 65 Issue 10, p1421-1430. 10p. 1 Diagram, 4 Charts.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:00015172
DOI:10.1111/aas.13941